Sadick Research Group has extensive experience in clinical trials of dermatological topical, oral and monoclonal drugs for all dermatological conditions including acne, rosacea, melasma, onychomycosis, atopic dermatitis, psoriasis and many more. Our tests for cutaneous safety and efficacy follow the protocol for FDA requirements as well as international guidelines. Additionally, we conduct trials evaluating systemic safety including ECGs, clinical chemical parameters and systemic absorption as well as histological and immunohistochemical effects.